Turkey’s health minister announced early Wednesday that three inactive COVID-19 vaccine candidates are ready for human trials.
Fahrettin Koca said 17 different COVID-19 vaccine candidates are currently being developed in Turkey, and among them, “three of our candidate vaccines have applied to the Turkish Medicines and Medical Devices Agency for starting testing on humans.”
“Our inactive vaccine that is in human experiment phase is about to start Phase 2. It is expected to start Phase 3 in April,” he said.
Turkey’s tourism officials hope #COVID19 vaccines will enable country to welcome some 25 million foreign visitors in 2021 after a decline caused by pandemichttps://t.co/yW8LtZXju8— DAILY SABAH (@DailySabah) January 5, 2021
Koca added that a Virus-Like Particle (VLP) vaccine, which is unique in the world, has reached the level for production for research and application for testing on humans soon.
He said the scientific capacity of Turkey is competent to be able to conduct research and development activities for all vaccine types.
“I believe the scientific and technical background of our country and the ambition and efforts of our scientists will bring us the best vaccines,” he added.
This article has been adapted from its original source.